No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ.
Malin T
MT
Engelmark
Kirsten Y
KY
Renkema
Ulf B
UB
Gyllensten
D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications / Q000235:genetics; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D013548:Sweden; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000821:virology; D019014:fas Receptor / Q000235:genetics*; D002578:Uterine Cervical Dysplasia / Q000235:genetics* / Q000821:virology
D019014:fas Receptor